Literature DB >> 24431649

A study of pelvic and para-aortic lymph node involvement in surgically staged endometrioid carcinoma of endometrium.

Rekha B Raghavendrachar1, Julian Crasta2, Premalatha T Siddartha3, Elizabeth M Vallikad3.   

Abstract

PURPOSE: The purpose of this study was to investigate the influence of the depth of myometrial invasion and tumor grade on lymph node involvement in endometrial carcinoma.
METHODS: Patients with endometrioid carcinoma of endometrium who underwent surgical staging between January 1999 and September 2010 under the division of gynecologic oncology were studied retrospectively. Patients treated by radiotherapy or chemotherapy before surgeries were excluded.
RESULTS: The study group included 61 patients. Six patients had lymph node metastasis, of which 83.3 % had >50 % myometrial invasion (P = 0.052). Grades 1, 2, and 3 were each seen in 33.3 % of them (P = 0.061). When the study group was divided into two sets, namely, those with <50 and >50 % myometrial invasion, the odds ratio was 10.3, which means that the chance of the prevalence of lymph node metastasis in the latter group is 10 times more.
CONCLUSIONS: Although the P value was not significant, the odds ratio reveals that there is an increased risk of lymph node positivity with deeper myometrial invasion. Surgical staging needs to be done for all operable cases of carcinoma endometrium to determine the prognosis and further management.

Entities:  

Keywords:  Endometrioid carcinoma; Myometrial invasion; Retroperitoneal lymphadenectomy

Year:  2013        PMID: 24431649      PMCID: PMC3763062          DOI: 10.1007/s13224-012-0317-7

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  5 in total

1.  Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.

Authors:  Srinivas Kondalsamy-Chennakesavan; Stijn van Vugt; Karen Sanday; Jim Nicklin; Russell Land; Lewis Perrin; Alex Crandon; Andreas Obermair
Journal:  Int J Gynecol Cancer       Date:  2010-10       Impact factor: 3.437

2.  Lymphadenectomy in high risk endometrial carcinoma stage I and II: no more morbidity and no need for external pelvic radiation.

Authors:  G. Berclaz; W. Hänggi; A. Kratzer-Berger; H. J. Altermatt; R. H. Greiner; E. Dreher
Journal:  Int J Gynecol Cancer       Date:  1999-07       Impact factor: 3.437

3.  Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers.

Authors:  Y Yokoyama; H Maruyama; S Sato; Y Saito
Journal:  Gynecol Oncol       Date:  1997-03       Impact factor: 5.482

4.  The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.

Authors:  D S Chi; R R Barakat; M J Palayekar; D A Levine; Y Sonoda; K Alektiar; C L Brown; N R Abu-Rustum
Journal:  Int J Gynecol Cancer       Date:  2008 Mar-Apr       Impact factor: 3.437

5.  Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis.

Authors:  D C Smith; O K Macdonald; C M Lee; D K Gaffney
Journal:  Int J Gynecol Cancer       Date:  2007-07-11       Impact factor: 3.437

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.